Low-Dose Rabbit Antithymocyte Globulin Versus Basiliximab Induction Therapy in Low-Risk Renal Transplant Recipients: 8-Year Follow-Up
2011 ◽
Vol 43
(2)
◽
pp. 458-461
◽
1997 ◽
Vol 11
(3)
◽
pp. 237-245
◽
2021 ◽
Vol 53
(7)
◽
pp. 2252-2260
1988 ◽
Vol 45
(4)
◽
pp. 701-705
◽